1. Home
  2. Author
  3. Batsman S

Batsman S

References (2)

Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779
Author(s) : Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW
Ref : Lancet Neurol , 7 :779 , 2008
Abstract :
PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779
PubMedID: 18672400

Title : Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study - Winblad_2006_Lancet_367_1057
Author(s) : Winblad B , Kilander L , Eriksson S , Minthon L , Batsman S , Wetterholm AL , Jansson-Blixt C , Haglund A
Ref : Lancet , 367 :1057 , 2006
Abstract :
PubMedSearch : Winblad_2006_Lancet_367_1057
PubMedID: 16581404